Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes
Clinical trial NCT05689424 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05689424
- Sponsor
- University of California, San Diego
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-01
- Primary completion
- 2026-06-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.